Travel? Shopping, Movie Trailer? Music video? Scams Exposed? News? Horoscopes? Investment. Search. We have an international audience so publish in different languages
LIVE NEWS STREAMS
Al Jazeera: BBC News: Bloomberg: DW: France 24: i24News24: News: Sky News: WSJ: Asianetnews: Euronews fr - pt - it - de - eng: - Arirang TV: - Perviy: - VOA:
BBC 1: 2: 3: 4 - Channel 4: E4: More 4: Film 4: Channel 5: PICK TV: International Fashion: ITV: 1: 2. 3: 4:
Thursday, June 9, 2016
#Lebanon - Beirut Hackathon Aims to Bring Tech Innovations to Refugees: Wall Street Journal
#Syria - Deadly air strikes hit Aleppo hospital: Al Jazeera English
ReNeuron (LON:RENE) making good progress in clinical trial, says CFO: ProactiveInvestors Stocktube
Researchers at Massachusetts Eye and Ear in Boston are using human retinal progenitor cells (hRPC) to possibly halt the progression of retinitis pigmentosa (RP).
Michael Hunt, chief financial officer, tells Proactive Investors “it’s important because the third patient marks the end of the first dose cohort in this particular study…so that’s good progression”.
They are carrying out a phase I/II clinical study on 15 acute sufferers of the degenerative conditions, and hunt says he expects the rest to be completed “over the course of this and possibly a little bit into next year” depending on the recruitment process.
www.reneuron.com/
http://www.4-traders.com/RENEURON-GROUP-PLC-4005458/
www.proactiveinvestors.co.uk › LON:RENE
ReNeuron Group PLC treats first patient in retinitis pigmentosa #RP trial https://t.co/OP386Bw3aS— Fighting Blindness (@fightngblindnes) March 16, 2016
EXECUTIVE INTERVIEW: $RENE discusses #cell-based technology platforms & potential #clinical data #catalysts #pharma https://t.co/If7dkyebxA— Edison (@Edison_Inv_Res) October 22, 2014
#USA - New Information About Brock Turner Revealed: ABC News
Trading Video: NZD/USD Rallies After RBNZ, S&P 500 Keeps Crawling to New Highs: Forex News by DailyFX
• Risk appetite trends continues to mark time with a slow but steady climb led by yet another S&P 500 11-month high
• The Dollar's tumble has run short on steam as we officially enter the communications blackout pre-FOMC
• NZD is this morning's top mover with an RBNZ hold that sent the currency soaring - the question is does it last?
Read the full article here:
https://www.dailyfx.com/forex/video/d...
Wednesday, June 8, 2016
#Israel - Death toll from mass shooting in central Tel Aviv rises to at least 3, several injured: BNO News
APPALING: Palestinians in #Gaza celebrating the SUCCESFUL Israeli bloodshed, their first HOLY attack during #Ramadan pic.twitter.com/3oZDWU5aCV
— Israel News Flash (@ILNewsFlash) June 8, 2016
SHATTERING UPDATE: Death toll of mass shooting terror attack in Tel Aviv rises to 3.
— Israel News Flash (@ILNewsFlash) June 8, 2016
4 y/o girl among victims. pic.twitter.com/XOo33s8ZhE
ValiRx (LON:VAL) in talks over cancer drug collaborations, says chief: ProactiveInvestors Stocktube
The company is to broaden the phase I/II clinical trial of its lead cancer drug to speed up the dose expansion stage, allowing it to complete the prostate cancer trial within the projected and regulatory-agreed time frame.
“A biotech business model is to take things from A to B and once you start reaching B, which in our case is Phase II clinical trials, we are starting to talk to big pharmaceutical companies or bigger biotech companies,” Vainikka says.
The company has also started preparatory work on a full efficacy study (phase III) of the drug in prostate cancer treatment.
www.valirx.com/
www.proactiveinvestors.com/LON:VAL/ValiRx
http://www.4-traders.com/VALIRX-PLC-22619385/
Beaufort's pleased to announce we've been appointed corporate broker for ValiRx https://t.co/IuGilZrKtj #VAL #ValiRx pic.twitter.com/hzOFxXLjm9
— Beaufort Securities (@BeaufortSec) June 7, 2016
#ValiRx #joint #venture awarded second US #patent... https://t.co/OmJROLEQw6 pic.twitter.com/oprgPJZWjB
— agencyIP (@AgencyIP) May 7, 2016
@BlueShareForum Quarterly update on clinical developments for #Valirx - listen at https://t.co/F6o9VhBZOy $val #biotechnology
— BRR Media UK (@brr_mediauk) June 8, 2016